Tarbox Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History

Tarbox Family Office’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$39K	–	231
2022 Q1	$39K	Hold	500	–	–	0.01%	206
2021 Q4	$44K	Hold	500	–	–	0.01%	240
2021 Q3	$39K	Hold	500	–	–	0.01%	271
2021 Q2	$42K	Sell	500 -11	-2%	-$872	0.01%	266
2021 Q1	$39K	Hold	511	–	–	0.01%	222
2020 Q4	$45K	Hold	511	–	–	0.01%	204
2020 Q3	$39K	Hold	511	–	–	0.01%	210
2020 Q2	$63K	Hold	511	–	–	0.02%	163
2020 Q1	$43K	Sell	511 -489	-49%	-$42.1K	0.01%	172
2019 Q4	$85K	Hold	1,000	–	–	0.02%	143
2019 Q3	$67K	Sell	1,000 -20	-2%	-$1.54K	0.02%	142
2019 Q2	$87K	Hold	1,020	–	–	0.03%	133
2019 Q1	$91K	Hold	1,020	–	–	0.03%	122
2018 Q4	$87K	Sell	1,020 -3	-0.3%	-$285	0.04%	120
2018 Q3	$99K	Hold	1,023	–	–	0.04%	121
2018 Q2	$96K	Buy	1,023 +3	+0.3%	+$263	0.04%	123
2018 Q1	$83K	Hold	1,020	–	–	0.03%	135
2017 Q4	$91K	Hold	1,020	–	–	0.04%	130
2017 Q3	$95K	Hold	1,020	–	–	0.04%	123
2017 Q2	$93K	Hold	1,020	–	–	0.05%	113
2017 Q1	$90K	Hold	1,020	–	–	0.05%	98
2016 Q4	$84K	Buy	1,020 +1,003	+5,900%	+$86.3K	0.05%	84
2016 Q3	$2K	Hold	17	–	–	﹤0.01%	418
2016 Q2	$1K	Hold	17	–	–	﹤0.01%	472
2016 Q1	$1K	Buy	+17	New	+$1.38K	﹤0.01%	486
2015 Q4	–	Sell	-10	Closed	-$1K	–	542
2015 Q3	$1K	Buy	+10	New	+$1.34K	﹤0.01%	459

Other funds holding BMRN

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Tarbox Family Office's BMRN Position: Q2 2022 in Review

Tarbox Family Office sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2022, closing a stake of 500 shares — an estimated $39K sold.

Tarbox Family Office first reported a position in BMRN in Q3 2015 and held it in 26 quarters. The position peaked at $99K in Q3 2018. 542 funds tracked by Wall St. Rank hold BMRN as of Q2 2022.

Tarbox Family Office reported no remaining BioMarin Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 500 BioMarin Pharmaceuticals shares in Q2 2022, an estimated $39K.
Tarbox Family Office first reported a position in BioMarin Pharmaceuticals in Q3 2015 and held it in 26 quarters.
Tarbox Family Office's BioMarin Pharmaceuticals position peaked at $99K in Q3 2018.
542 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.